{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:51:59Z","timestamp":1791244319723,"version":"4.1.0"},"reference-count":19,"publisher":"American Association of Avian Pathologists (AAAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avian Diseases"],"published-print":{"date-parts":[[2025,8,5]]},"abstract":"<jats:p>Nota de investigaci\u00f3n- Respuestas de anticuerpos obtenidas mediante la vacunaci\u00f3n con un virus LaSota recombinante que expresa la prote\u00edna de la esp\u00edcula del virus de la bronquitis infecciosa aviar en pollos con anticuerpos maternos. Se evalu\u00f3 la vacunaci\u00f3n con una cepa recombinante del virus de la enfermedad de Newcastle LaSota (LS) que expresa el ectodominio la prote\u00edna de la esp\u00edcula del virus de la bronquitis infecciosa (VBI) de tipo Arkansas (Ark) y el factor estimulante de colonias de granulocitos y macr\u00f3fagos (GMCSF) (rLS\/ArkSe.GMCSF, donde rLS significa una cepa LaSota recombinante) en pollos de origen comercial con anticuerpos maternos contra el virus de Newcastle y el virus de la bronquitis infecciosa aviar. Los pollos se vacunaron ocularmente con el virus rLS\/ArkSe.GMCSF a los dos, ocho, 15 o 30 d\u00edas de edad. Los pollos control se vacunaron con un virus recombinante rLS (que no expresaba la prote\u00edna de la esp\u00edcula del del virus de la bronquitis infecciosa ni al GMCSF) en los mismos d\u00edas. Pollos libres de pat\u00f3genos espec\u00edficos tambi\u00e9n fueron vacunados con cualquiera de los virus a los dos d\u00edas de edad. Los resultados mostraron la detecci\u00f3n de ARN del virus de Newcastle en fluidos lagrimales de pollos vacunados, lo que indica una replicaci\u00f3n exitosa del virus recombinante en sitios de la mucosa periocular. Se detect\u00f3 inmunoglobulina IgA contra el virus de bronquitis en fluidos lagrimales y los anticuerpos s\u00e9ricos contra el mismo virus se determinaron por ELISA usando placas recubiertas con prote\u00edna recombinante Ark S1 del virus de bronquitis. La vacunaci\u00f3n a los dos d\u00edas de edad con el virus rLS\/ArkSe.GMCSF en pollos con anticuerpos maternales provoc\u00f3 una respuesta de inmunoglobulina IgA en fluidos lagrimales. Pollos con anticuerpos maternales vacunados con el virus rLS\/ArkSe.GMCSF a los ocho d\u00edas de edad mostraron niveles de IgA en fluidos lagrimales que no difirieron significativamente de los niveles alcanzados tras la vacunaci\u00f3n a los dos d\u00edas de edad. La vacunaci\u00f3n a los 30 d\u00edas de edad no result\u00f3 en un aumento de los niveles de IgA contra bronquitis en fluidos lagrimales de aves con anticuerpos maternales en comparaci\u00f3n con aves no vacunadas con inmunidad materna. La vacunaci\u00f3n con el virus rLS\/ArkSe.GMCSF en pollos con inmunidad materna result\u00f3 en respuestas limitadas de anticuerpos s\u00e9ricos contra el virus de la bronquitis infecciosa y el virus de la enfermedad de Newcastle. Concluimos que la vacunaci\u00f3n con el virus rLS\/ArkSe.GMCSF induce IgA contra el virus e la bronquitis infecciosa en la mucosa periocular, pero induce respuestas limitadas de anticuerpos s\u00e9ricos en pollos con inmunidad materna contra el virus de la enfermedad de Newcastle.<\/jats:p>","DOI":"10.1637\/aviandiseases-d-25-00035","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T08:32:05Z","timestamp":1758184325000},"page":"301-306","source":"Crossref","is-referenced-by-count":2,"title":["Antibody Responses Elicited by Vaccination with Recombinant LaSota Virus Expressing IBV Spike in Chickens with Maternal Antibodies"],"prefix":"10.1637","volume":"69","author":[{"given":"Camila","family":"Cuadrado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Breedlove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroldo","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1212","reference":[{"key":"4","doi-asserted-by":"crossref","unstructured":"P Deka, S Das, P Deka,  \"Curr J Appl Sci Technol.\"  39, \"Influence of maternal antibody on the efficacy of Newcastle disease vaccination in broilers.\" 108 (2020)","DOI":"10.9734\/cjast\/2020\/v39i730581"},{"key":"5","doi-asserted-by":"crossref","unstructured":"SP Mondal  and SA Naqi  \"Vet Immunol Immunopathol.\"  79, \"Maternal antibody to infectious bronchitis virus: its role in protection against infection and development of active immunity to vaccine.\" 31 (2001)","DOI":"10.1016\/S0165-2427(01)00248-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"WP Heuschele  and BC Easterday  \"J Infec Dis.\"  121, \"Local immunity and persistence of virus in the tracheas of chickens following infection with Newcastle disease virus. II. Immunofluorescent and histopathologic studies.\" 497 (1970)","DOI":"10.1093\/infdis\/121.5.497"},{"key":"8","doi-asserted-by":"crossref","unstructured":"WP Heuschele  and BC Easterday  \"J Infect Dis.\"  121, \"Local immunity and persistence of virus in the tracheas of chickens following infection with Newcastle disease virus. I. Organ culture studies.\" 486 (1970)","DOI":"10.1093\/infdis\/121.5.486"},{"key":"11","doi-asserted-by":"crossref","unstructured":"R Espejo, C Breedlove, H Toro,  \"Avian Dis.\"  68, \"Immune responses in the Harderian gland after Newcastle disease vaccination in chickens with maternal antibodies.\" 192 (2024)","DOI":"10.1637\/aviandiseases-D-24-00007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"DA Sutton, SP Allen, CM Fuller, et al.  \"J Virol Meth.\"  265, \"Development of an avian avulavirus 1 (AAvV-1) L-gene real-time RT-PCR assay using minor groove binding probes for application as a routine diagnostic tool.\" 9 (2019)","DOI":"10.1016\/j.jviromet.2018.12.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"C Cuadrado, C Breedlove, Santen Ev, et al.  \"Avian Dis.\"  68, \"Protection against infectious bronchitis virus vaccine recombinants and chicken-selected vaccine subpopulations.\" 89 (2024)","DOI":"10.1637\/aviandiseases-D-23-00064"},{"key":"17","doi-asserted-by":"crossref","unstructured":"RA Zegpi, S Gulley, VL van Santen, et al.  \"Avian Dis.\"  63, \"Infectious bronchitis virus vaccination at day one of age further limits cross-protection.\" 302 (2019)","DOI":"10.1637\/12009-120518-Reg.1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"F Saiada, F Eldemery, RA Zegpi, et al.  \"Avian Dis.\"  63, \"Early vaccination of chickens induces suboptimal immunity against infectious bronchitis virus.\" 38 (2019)","DOI":"10.1637\/11951-081418-Reg.1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"RA Zegpi, L He, Q Yu, et al.  \"Avian Dis.\"  64, \"Limited protection conferred by recombinant Newcastle disease virus expressing infectious bronchitis spike protein.\" 53 (2020)","DOI":"10.1637\/0005-2086-64.1.53"},{"key":"13","unstructured":"P. Villegas,  \"A laboratory manual for the isolation, identification and characterization of avian pathogens.\"  \"Titration of biological suspensions.\" 355 (2016)"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Z Khalid, L He, Q Yu, et al.  \"Avian Dis.\"  65, \"Enhanced protection by recombinant Newcastle disease virus expressing infectious bronchitis virus spike-ectodomain and chicken granulocyte-macrophage colony-stimulating factor.\" 364 (2021)","DOI":"10.1637\/aviandiseases-D-21-00032"},{"key":"18","doi-asserted-by":"crossref","unstructured":"CL Jones, RA MacDonald, CS Hosking, et al.  \"J Immunol Meth.\"  105, \"Estimating the relative avidity of mucosal IgA for antigen.\" 111 (1987)","DOI":"10.1016\/0022-1759(87)90420-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"H Toro  and I Fernandez  \"J Vet Med B.\"  41, \"Avian infectious bronchitis: specific lachrymal IgA level and resistance against challenge.\" 467 (1994)","DOI":"10.1111\/j.1439-0450.1994.tb00252.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"PH. Russell,  \"Vet Immunol Immunopathol.\"  37, \"Newcastle disease virus: virus replication in the Harderian gland stimulates lacrimal IgA; the yolk sac provides early lacrimal IgG.\" 151 (1993)","DOI":"10.1016\/0165-2427(93)90062-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"PH Russell  and GO Ezeifeka  \"Vaccine.\"  13, \"The Hitchner B1 strain of Newcastle disease virus induces high levels of IgA, IgG and IgM in newly hatched chicks.\" 61 (1995)","DOI":"10.1016\/0264-410X(95)80012-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Z Khalid, L He, Q Yu, et al.  \"Avian Dis.\"  65, \"Enhanced protection by recombinant Newcastle disease virus expressing infectious bronchitis virus spike ectodomain and chicken granulocyte-macrophage colony-stimulating factor.\" 364 (2021)","DOI":"10.1637\/aviandiseases-D-21-00032"},{"key":"16","doi-asserted-by":"crossref","unstructured":"H Toro, P Lavaud, P Vallejos, et al.  \"Avian Dis.\"  37, \"Transfer of IgG from serum to lachrimal fluid in chickens.\" 60 (1993)","DOI":"10.2307\/1591458"},{"key":"1","doi-asserted-by":"crossref","unstructured":"H. Toro,  \"Avian Dis.\"  65, \"Global control of infectious bronchitis requires replacing live attenuated vaccines by alternative technologies.\" 635 (2021)","DOI":"10.1637\/aviandiseases-D-21-00105"}],"container-title":["Avian Diseases"],"original-title":[],"link":[{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-69\/issue-3\/aviandiseases-D-25-00035\/Antibody-Responses-Elicited-by-Vaccination-with-Recombinant-LaSota-Virus-Expressing\/10.1637\/aviandiseases-D-25-00035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:57:13Z","timestamp":1791241033000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-69\/issue-3\/aviandiseases-D-25-00035\/Antibody-Responses-Elicited-by-Vaccination-with-Recombinant-LaSota-Virus-Expressing\/10.1637\/aviandiseases-D-25-00035.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1637\/aviandiseases-d-25-00035","relation":{},"ISSN":["0005-2086","1938-4351"],"issn-type":[{"value":"0005-2086","type":"print"},{"value":"1938-4351","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]}}}